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Abstract
Background
Rotavirus is a leading cause of diarrhoeal mortality in children but there is considerable dis-
agreement about how many deaths occur each year.
Methods and findings
We compared CHERG, GBD and WHO/CDC estimates of age under 5 years (U5) rotavirus
deaths at the global, regional and national level using a standard year (2013) and standard
list of 186 countries. The global estimates were 157,398 (CHERG), 122,322 (GBD) and
215,757 (WHO/CDC). The three groups used different methods: (i) to select data points for
rotavirus-positive proportions; (ii) to extrapolate data points to individual countries; (iii) to
account for rotavirus vaccine coverage; (iv) to convert rotavirus-positive proportions to rota-
virus attributable fractions; and (v) to calculate uncertainty ranges. We conducted new anal-
yses to inform future estimates. We found that acute watery diarrhoea was associated with
87% (95% CI 83–90%) of U5 diarrhoea hospitalisations based on data from 84 hospital sites
in 9 countries, and 65% (95% CI 57–74%) of U5 diarrhoea deaths based on verbal autopsy
reports from 9 country sites. We reanalysed data from the Global Enteric Multicenter Study
(GEMS) and found 44% (55% in Asia, and 32% in Africa) rotavirus-positivity among U5
acute watery diarrhoea hospitalisations, and 28% rotavirus-positivity among U5 acute
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watery diarrhoea deaths. 97% (95% CI 95–98%) of the U5 diarrhoea hospitalisations that
tested positive for rotavirus were entirely attributable to rotavirus. For all clinical syndromes
combined the rotavirus attributable fraction was 34% (95% CI 31–36%). This increased by a
factor of 1.08 (95% CI 1.02–1.14) when the GEMS results were reanalysed using a more
sensitive molecular test.
Conclusions
We developed consensus on seven proposals for improving the quality and transparency of
future rotavirus mortality estimates.
Introduction
Rotavirus is a leading cause of diarrhoeal mortality in children less than five years old (U5),
but there is considerable disagreement about how many rotavirus deaths occur each year.
Recent estimates from different sources range from ~120,000 to ~215,000 [1–3]. Accurate
rotavirus mortality estimates help governments and donors prioritise public health interven-
tions and provide a basis for assessing the impact of immunization on mortality rates. Conflict-
ing estimates from different sources create confusion and can delay the introduction of
important diarrhoea mortality prevention measures, such as rotavirus vaccines.
In recent years, three groups have produced estimates of rotavirus deaths:
1. CHERG—the Child Health Epidemiology Reference Group of the World Health Organiza-
tion (WHO) and UNICEF. CHERG is now referred to as MCEE—the Maternal and Child
Epidemiology Estimation group;
2. GBD—the Global Burden of Disease Study, a collaboration led by the Institute for Health
Metrics and Evaluation (IHME); and,
3. WHO/CDC—the WHO and Centers for Disease Control and Prevention (joint estimates).
A meeting coordinated by WHO (Geneva, March 2015) facilitated the initial discussions on
the differences between the currently available rotavirus mortality estimates. This work builds
on a previous assessment of differences between CHERG and GBD estimates of all-cause U5
diarrhoea deaths [4]. Several gaps in the evidence were identified at an early stage in the pro-
cess, and one important task was to conduct new analyses to help bridge these gaps. First, rota-
virus is not associated clinically with acute bloody (dysenteric) diarrhoea and rarely with
persistent diarrhoea (of 14 days duration or more). As a result, many of the rotavirus-positive
proportions reported in hospital surveillance networks, and in the literature, exclude these
cases, and simply report the rotavirus-positive proportion among hospitalised children with
acute watery diarrhoea. If this proportion is applied to all episodes of diarrhoea resulting in
hospitalisation, it will result in overestimates. Second, there is very limited evidence to inform
whether the distribution of clinical syndromes for U5 diarrhoea hospitalisations (% acute
watery, % acute bloody, % persistent) is similar to, and thus a reasonable proxy for, the distri-
bution of clinical syndromes for U5 diarrhoea deaths. Most approaches assume that rotavirus-
positivity among diarrhoea hospitalisations is a reasonable proxy for rotavirus-positivity
among diarrhoea deaths. However, the two proportions are rarely reported in the same study
population. Third, to date there has been no explicit quantification of the rotavirus attributable
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fraction among U5 diarrhoea hospitalisations, or the extent to which that varies depending on
the type of diagnostic test used.
The aim of this manuscript is to compare the existing rotavirus mortality estimates, explain
the reasons for differences, provide evidence to inform key areas of uncertainty, and propose
improvements for future estimates.
Methods
We used a range of methods and sources of data. First, we compared existing estimates of U5
rotavirus deaths at the global, regional and national level and identified key differences in the
approaches used. Second, we used data from a large number of hospitals to estimate the pro-
portion of U5 diarrhoea hospitalisations that were acute watery, acute bloody and persistent.
Third, we used data from verbal autopsy studies to estimate the proportion of U5 diarrhoea
deaths that were acute watery, acute bloody and persistent. Fourth, we calculated the propor-
tion of U5 diarrhoea hospitalisations and U5 diarrhoea deaths that were rotavirus-positive in
each of the African and Asian sites included in the Global Enteric Multicenter Study (GEMS).
Fifth, we used data from GEMS to estimate the proportion of rotavirus-positive U5 diarrhoea
hospitalisations that were entirely attributable to rotavirus, and quantified the increase in the
rotavirus attributable fraction when a more sensitive molecular test was used to determine
rotavirus-positivity.
All data used in this study were anonymized prior to access and analysis. Please see support-
ing information (S1 Table) for details about institutional ethical approvals, and how and where
the data were collected.
U5 rotavirus deaths: Comparison of estimates from GBD, CHERG and
WHO/CDC
An independent reviewer (AC) compared the methods and data files published by the Global
Burden of Disease 2013 Study (GBD 2013) [1, 5], CHERG [2, 6] and WHO/CDC [3, 7]. GBD
provided a data file with country specific estimates of U5 rotavirus deaths [8].
We compared global, regional and national estimates of U5 deaths, U5 diarrhoea deaths
and U5 rotavirus deaths for the year 2013 using a standard list of 186 countries (S1 File).
CHERG did not report country estimates of U5 rotavirus deaths, so we multiplied country
estimates of U5 diarrhoea deaths for the year 2013 by regional estimates of the proportion of
U5 diarrhoea deaths due to rotavirus, as reported by CHERG for the year 2010. We removed
two countries from the GBD list (Taiwan, Palestine) and seven from the WHO/CDC list
(Cook Islands, Monaco, Nauru, Niue, Palau, St Kitts and Nevis, San Marino, Tuvalu) because
they did not appear in both GBD and WHO/CDC datasets. GBD, CHERG and WHO/CDC
used different classifications for grouping countries. For the purpose of this comparison exer-
cise, all countries were grouped using the WHO classification system i.e. AFRO, AMRO,
EMRO, EURO, SEARO, WPRO [9].
Clinical syndromes of U5 diarrhoea hospitalisations: Acute watery, acute
bloody, persistent
To estimate the proportion of U5 diarrhoea hospitalisations that were acute watery, acute
bloody and persistent, we used data from 84 hospitals in 9 countries:
1. 50 hospitals (5 in Indonesia, 42 in Rwanda and 3 in Zambia) from the WHO-coordinated
Global Sentinel Site Rotavirus Surveillance Network—GRSN [10];
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2. 7 hospitals from the Indian National Hospital Rotavirus Surveillance Network—NRSN
(Delhi, Hyderabad, Kolenchery, Ludhiana, Tirupati, Trichy and Vellore); and;
3. 27 hospitals included in the Global Enteric Multicenter Study—GEMS (1 in Bangladesh, 4
in India, 6 in Gambia, 10 in Kenya, 6 in Mozambique). Methods for recruiting and enroll-
ing moderate-to-severe diarrhoea (MSD) cases in GEMS have been described in detail else-
where [11]. We included 5 of the 7 GEMS sites in this particular analysis. Mali and Pakistan
were excluded because they rarely hospitalised children [12].
To be included, sites had to be major paediatric hospitals or district hospitals with100
children aged<5 years hospitalised for diarrhoea. For GEMS sites, inpatients included chil-
dren with inpatient status at enrolment as well as children who were admitted after enrolment.
Data had to be available for the full 12 months of the year (to account for rotavirus seasonality)
and obtained before the introduction of rotavirus vaccination. Diagnoses were grouped into
acute watery, acute bloody and persistent diarrhoea based on coding systems in place in the
country and site. Acute syndromes were<14 days in duration, and persistent were14 days.
All GRSN, NRSN and GEMS sites excluded patients who were defined as “persistent” at the
time of enrolment, but included patients who became persistent after enrolment. Paediatric
logbooks were reviewed in the Indian NRSN sites and Indonesian GRSN sites. Cases were
excluded (2% in India, 8% in Indonesia) if there was not enough information in the logbook to
categorise them. Electronic discharge data were used in Rwanda and Zambia so all cases had
to be coded into a category.
The Stata 14 command metaprop was used for meta-analysis of the proportion of U5 diar-
rhoea hospitalisations associated with acute watery diarrhoea (AWD), with random effects
and exact confidence intervals [13].
Clinical syndromes of U5 diarrhoea deaths
The clinical syndromes for U5 diarrhoea deaths were assessed using published verbal autopsy
data from 5 demographic surveillance sites in Bangladesh, Ethiopia, Pakistan, Tanzania and
Uganda [14] and verbal autopsy data from 4 sites in Cameroon, Malawi, Niger and Nigeria
(Henry Kalter personal communication). The data came from investigation of child deaths
identified in a household survey, including deaths in the community or a health facility, using
the birth history method with follow-up questions to family members of the deceased child
(S1 Table). All data sources included children aged<5 years and covered a period of at least
12 months, so they reflect all seasons.
The Stata 14 command metaprop was also used for meta-analysis of the proportion of U5
diarrhoea deaths associated with AWD, with random effects and exact confidence intervals
[13].
Rotavirus-positive proportion in U5 diarrhoea hospitalisations and U5
diarrhoea deaths in GEMS
We calculated the rotavirus-positive proportions among MSD cases aged<5 years who were
admitted to hospital in 6 of the 7 country sites included in GEMS, using the conventional EIA
(Enzyme immunoassay) test results. We excluded Mozambique because there was an unusu-
ally high number of positive samples in healthy controls, and only 55% of the rotavirus-
positive cases and 7% of the rotavirus-positive healthy controls were shown to be rotavirus-
positive on retesting with a different EIA test kit.
We calculated rotavirus-positive proportions separately for acute watery diarrhoea and all
clinical syndromes combined (acute watery, acute bloody and persistent cases). In GEMS, if
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more than 9 children with MSD were identified in a fortnight, only the first 9 children were
enrolled and tested for rotavirus; the remainder were recorded on a log and assumed to have
the same rotavirus-positive proportion as enrolled cases that were identified in the same fort-
night, age stratum (0-11m, 12-23m, 24-59m) and diarrhoea syndrome (acute watery, acute
bloody, persistent).
We also calculated the proportion of U5 deaths that: a) tested positive for rotavirus within 7
days of death; and, b) had diarrhoea coded as the first or second cause of death on their verbal
autopsy (VA) report. Rotavirus-positive children with a missing VA report (~20%) were
assumed to have the same cause-of-death breakdown as rotavirus-positive children with a VA
report.
For completeness, we also calculated the rotavirus-positive proportion among healthy con-
trols as well as MSD cases that were not admitted to hospital.
Proportion of rotavirus-positive U5 diarrhoea hospitalisations attributable
to rotavirus in GEMS
GEMS tested for a wide range of enteric pathogens in the stools of MSD cases and healthy
community controls without diarrhoea matched to cases by age, gender, and residence; con-
trols were enrolled within 14 days of the index case. GEMS also included information about
whether MSD cases were admitted to hospital or not.
We used multiple conditional logistic regression to calculate the odds ratio of rotavirus EIA
positivity in hospitalized MSD cases vs matched healthy controls adjusted for the presence of
other pathogens. All syndromes of diarrhoea were included. We then calculated the attribut-
able fraction (AF) as described by Bruzzi et al [15]. These methods were the same as those used
to estimate attributable fractions in the main GEMS analysis [12, 16]. However, we restricted
the analysis to hospitalised cases, thought to be a better proxy for estimating rotavirus-
attributable mortality than all MSD cases. We excluded Mozambique from all AF analyses due
to concerns about the quality of the EIA testing, and did not estimate individual AFs for Mali
and Pakistan because hospitalisation for diarrhoea was very rare in these sites.
Using these attributable fractions, which represent the fraction of hospitalised MSD cases
with disease attributable to rotavirus, we calculated the attributable fraction among the
exposed (AFe). The AFe represents the fraction of rotavirus positive cases who have disease
caused by rotavirus. The rotavirus-positive proportions used to derive the AF and AFe were
based only on the children with MSD that were tested for rotavirus. These were age-specific
(0-11m, 12-23m, 24-59m) and did not involve extrapolation to non-enrolled MSD cases.
Finally, we used previously described methods [17] to calculate the rotavirus attributable
fraction based on quantitative Polymerase Chain Reaction (qPCR). We restricted the analysis
to a subset of 721 hospital cases and matched controls, and calculated the AF for all country
sites combined, excluding Mozambique. To quantify the test performance of EIA compared to
qPCR, we repeated this analysis for EIA test results, and calculated the ratio between the two
attributable fractions. All syndromes of diarrhoea were included. Confidence intervals were
calculated by bootstrapping with 1000 iterations.
Results
Comparison exercise
GBD produce their own estimates of U5 deaths [18], whereas CHERG and WHO/CDC use
U5 deaths from the UN Inter-agency Group for Child Mortality Estimation (IGME)[19]. Both
GBD and IGME estimate approximately 6.3 million U5 deaths globally in 2013 (Table 1) but
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some important differences exist at country/regional levels e.g. ~739,000 (GBD) vs ~845,000
(IGME) in the Eastern Mediterranean Region (EMRO). The main methodological differences
between GBD and IGME have been described in detail elsewhere and include the choice of
data points selected (vital registration, census and household surveys) and fitting methods
used [20].
GBD and CHERG produce their own estimates of the proportion of U5 deaths due to diar-
rhoea [5, 6]; WHO/CDC use the CHERG estimates. GBD and CHERG estimated that 8–9% of
U5 deaths were caused by diarrhoea at the global level in the year 2013 (Table 1). Differences
in GBD and CHERG estimates for the South East Asia (SEARO) region (6% vs 10%) are driven
by differences in estimates for India (6% vs 10%) where U5 diarrhoea deaths are ~80,000 vs
~140,000 respectively (Table 1). In other regions there is more agreement. Estimates for the
African (AFRO) region are consistent overall (10% vs 10%) but there are still large differences
at country level e.g. Zimbabwe (Fig 1).
Methodological differences between GBD and CHERG have been described in detail else-
where [4]. In brief, CHERG excluded verbal autopsy studies that only investigated a single
cause of death and data points from incomplete vital registration systems in higher mortality
Table 1. Comparison of CHERG, GBD and WHO/CDC estimates of U5 deaths, U5 diarrhoea deaths and U5 rotavirus deaths in the year 2013 by
WHO region, and for selected large countries.
GLOBAL AFRO AMRO EMRO EURO SEARO WPRO Bangladesh DR
Congo
India Indonesia
U5 deaths
UN (IGME) used by
CHERG
6,282,254 2,977,576 227,475 845,286 136,850 1,700,178 394,889 129,433 319,977 1,340,055 136,371
GBD 6,271,643 3,164,861 248,643 738,702 130,573 1,604,028 384,836 128,228 340,416 1,249,673 148,807
WHO/CDC - - - - - - - - - - -
Proportion of U5 deaths
due to diarrhoea
CHERG 0.09 0.10 0.04 0.10 0.04 0.10 0.06 0.06 0.11 0.10 0.06
GBD 0.08 0.10 0.05 0.12 0.03 0.06 0.02 0.01 0.17 0.06 0.06
WHO/CDC - - - - - - - - - - -
U5 diarrhoea deaths
CHERG 577,508 293,289 9,297 84,592 5,689 162,298 22,344 8,298 33,730 140,451 7,505
GBD 519,485 312,297 11,923 88,071 3,694 94,574 8,926 1,715 57,344 80,188 8,694
WHO/CDC 577,508 293,289 9,297 84,592 5,689 162,298 22,344 8,298 33,730 140,451 7,505
Proportion of U5
diarrhoea deaths due to
Rotavirus
CHERG 0.27 0.27 0.23 0.31 0.26 0.26 0.33 0.26 0.27 0.26 0.26
GBD 0.24 0.24 0.18 0.18 0.26 0.27 0.42 0.12 0.13 0.26 0.37
WHO/CDC 0.37 0.39 0.26 0.36 0.31 0.35 0.43 0.33 0.40 0.34 0.50
U5 rotavirus diarrhoea
deaths
CHERG 157,398 78,601 2,176 26,477 1,473 41,386 7,284 2,116 9,040 35,815 1,914
GBD 122,322 73,758 2,178 15,984 976 25,637 3,790 202 7,523 21,205 3,176
WHO/CDC 215,757 115,023 2,455 30,577 1,752 56,287 9,664 2,723 13,526 47,082 3,771
Region and global estimates may differ from official WHO/CDC, CHERG and GBD estimates because a standard set of countries and regions was used and
no rounding was done prior to aggregation.
https://doi.org/10.1371/journal.pone.0183392.t001
Estimating rotavirus deaths in children aged <5 years
PLOS ONE | https://doi.org/10.1371/journal.pone.0183392 September 11, 2017 6 / 18
settings. GBD included these data points and adjusted for missing data. GBD also included
unpublished data points obtained under third party data use agreements whereas CHERG
only use publicly available data points [21].
All three groups produce their own estimates of the proportion of U5 diarrhoea deaths that
are attributable to rotavirus. For the year 2013, the global proportions were 24% (GBD), 27%
(CHERG) and 37% (WHO/CDC). These correspond to 122,322 (GBD), 157,398 (CHERG)
and 215,757 (WHO/CDC) U5 rotavirus deaths (Table 1). Fig 2 shows the extent of variation in
the fraction of diarrhoea deaths attributed to rotavirus across countries within each WHO
region. There are large differences in some countries; for example, in DR Congo the propor-
tions are 13% (GBD), 27% (CHERG) and 40% (WHO/CDC).
The three groups used different methods to:
1. select data points (rotavirus-positive proportions);
2. extrapolate data points to individual countries;
3. account for rotavirus vaccine coverage;
4. convert rotavirus-positive proportions to rotavirus attributable fractions; and,
5. calculate uncertainty ranges.
A more detailed description of these differences can be found in the supporting informa-
tion (S1 Appendix).
Fig 1. Country-level differences in GBD vs CHERG estimates of the proportion of U5 deaths due to
diarrhoea in the year 2013 by WHO region.
https://doi.org/10.1371/journal.pone.0183392.g001
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Clinical syndromes for U5 diarrhoea hospitalisation
Table 2 shows the distribution of clinical syndromes for U5 diarrhoea hospitalisations for vari-
ous sites in Africa and Asia. A meta-analysis including data from all GRSN, NRSN and GEMS
sites suggests that acute watery diarrhoea was associated with 87% (95% CI 83–90%) of U5
diarrhoea hospitalisations (Fig 3) but there was substantial evidence for heterogeneity (I-
squared 99.08%, p = 0.00) between the studies. The GEMS site in Bangladesh (Mirzapur) had a
very high rate of acute bloody diarrhoea for reasons that are not clear.
Clinical syndromes for U5 diarrhoea deaths
Table 2 shows the distribution of clinical syndromes for U5 diarrhoea deaths. A meta-analysis
suggests that acute watery diarrhoea was associated with 65% (95% CI 57–74%) of U5 diar-
rhoea deaths (Fig 4) but again there was substantial evidence for heterogeneity between the
studies (I-squared 92.06%, p = 0.00). In four of the nine countries with verbal autopsy data, the
clinical syndromes of diarrhoea deaths were compared for those who died in any type of health
facility and those who died in the home, as reported by the family respondent. Most of deaths
were in the home (Cameroon 70%, Malawi 50%, Niger 86% and Nigeria 78%) but the distribu-
tion of acute watery, acute bloody and persistent diarrhoea was similar irrespective of the place
of death (Kalter, personal communication).
Rotavirus-positive proportion in U5 diarrhoea hospitalisations and U5
diarrhoea deaths in GEMS
For all GEMS sites combined (excluding Mozambique), rotavirus was detected (EIA-positive)
in 44% of acute watery U5 diarrhoea hospitalisations (55% in Asia, and 32% in Africa)
Fig 2. Country-level variation in the fraction of U5 diarrhoea deaths due to rotavirus in the year 2013
by source of estimates and by WHO region.
https://doi.org/10.1371/journal.pone.0183392.g002
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Table 2. Number and proportion of acute watery, acute bloody and persistent cases among U5 diarrhoea hospitalisations and U5 diarrhoea deaths
in various settings before rotavirus vaccine introduction.
Source Study
location
Study type Study
period
Diarrhoea
outcome
Age TotalΔ
n
Acute
Watery
n
Acute
Bloody
n
Persis-tent*
n
Acute
Watery
%
Acute
Bloody
%
Persis-tent
%
Clinical syndromes of U5 diarrhoea hospitalisations
GRSN Indonesia Surveillance
hospitals (n = 5)
2014–15 Inpatients <5yrs 1840 1695 110 35 92% 6% 2%
Rwanda Surveillance
hospitals (n = 42)
2012 Inpatients <5yrs 9097 8878 199 20 98% 2% 0.2%
Zambia Surveillance
hospitals (n = 3)
2009–11 Inpatients <5yrs 4381** 3761 15 - 86% 0.3% -
NRSN India Surveillance
hospitals (n = 7)
2013–14 Inpatients <5yrs 5156 4940 196 20 96% 4% 0.4%
GEMS Bangladesh Case control study
hospitals (n = 1)
2007–10 Inpatients <5yrs 337 171 154 11 51% 46% 3%
India Case control study
hospitals (n = 4)
2007–10 Inpatients <5yrs 437 411 17 10 94% 4% 2%
Gambia Case control study
hospitals (n = 6)
2007–10 Inpatients <5yrs 440 397 14 28 90% 3% 6%
Kenya Case control study
hospitals (n = 10)
2007–10 Inpatients <5yrs 175 129 3 44 74% 1% 25%
Mozambique Case control study
hospitals (n = 6)
2007–10 Inpatients <5yrs 633 579 6 48 91% 1% 8%
Clinical syndromes of U5 diarrhoea deaths
Verbal Bangladesh Demographic
surveillance (16)
2003–11 Deaths 1-
59m
59 43 7 9 73% 12% 15%
autopsy
studies
Pakistan Demographic &
Health Survey (16)
2006–7 Deaths 1-
59m
318 213 22 83 67% 7% 26%
Cameroon Subnational
household
survey***
2006–10 Deaths 1-
59m
166 125 20 22 75% 12% 13%
Ethiopia Demographic
surveillance (16)
2003–12 Deaths 1-
59m
60 19 6 35 32% 10% 58%
Malawi Subnational
household
survey***
2008–11 Deaths 1-
59m
149 118 18 13 79% 12% 9%
Niger Demographic &
Health Survey***
2006–10 Deaths 1-
59m
160 104 32 24 65% 20% 15%
Nigeria Demographic &
Health Survey***
2009–13 Deaths 1-
59m
537 435 70 32 81% 13% 6%
Tanzania Demographic
surveillance (16)
2000–11 Deaths 1-
59m
80 48 13 19 60% 16% 24%
Uganda Demographic
surveillance (16)
2007–10 Deaths 1-
59m
77 37 9 31 48% 12% 40%
ΔTotals for GEMS sites do not sum exactly due to rounding
*GRSN, NRSN and GEMS persistent cases include only those children who progressed to ‘persistent’ status (14+ days duration) after acute admission
** 605 cases in Zambia were classified as ‘non-infectious diarrhoea’, which is likely to include persistent cases as well as other cases that could not be
classified as acute watery or acute bloody diarrhoea.
*** Henry Kalter, personal communication
https://doi.org/10.1371/journal.pone.0183392.t002
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Fig 3. Meta-analysis showing the proportion of U5 diarrhoea hospitalisations associated with acute
watery diarrhoea (AWD) for selected sites in Africa and Asia.
https://doi.org/10.1371/journal.pone.0183392.g003
Fig 4. Meta-analysis showing the proportion of U5 diarrhoea deaths associated with acute watery
diarrhoea (AWD) for selected sites in Africa and Asia.
https://doi.org/10.1371/journal.pone.0183392.g004
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(Table 3). When all clinical syndromes of diarrhoea were included, the rotavirus-positive pro-
portion was 38% (44% in Asia; 30% in Africa).
Rotavirus was detected (EIA-positive) in 32% (12/37) of children aged<5yrs that died
within 7 days of enrolment at any type of health facility with acute watery MSD. Seven of the
rotavirus-positive children that died had a VA report, and 6 of these children (86%) had diar-
rhoea coded as a primary or secondary cause of death. Assuming that children with rotavirus
who lacked a VA report died from diarrhoea at the same rate as those with a report, the frac-
tion of U5 diarrhoea deaths that were rotavirus-positive was estimated to be 28% (10/37)
(Table 3). It was not possible to consider all syndromes because there were very few acute
bloody diarrhoea deaths (n = 3) and no persistent cases were eligible for inclusion in this anal-
ysis due to the short 7-day follow-up period.
The rotavirus-positive proportion was 3% in healthy controls. The rotavirus-positive preva-
lence in MSD inpatients was approximately double the rotavirus-positive prevalence in MSD
outpatients. 10% (147/1438) of inpatients and 20% (1782/8832) of outpatients had no detected
pathogen using conventional testing methods.
Table 3. Number and proportion of rotavirus infections in healthy controls and different types of diarrhoea cases aged <5yrs in GEMS.
Bangladesh India Pakistan ASIA Gambia Kenya Mali AFRICA TOTAL
Controls Number positive 74 42 66 182 42 39 43 124 306
Number tested 2465 2014 1838 6317 1569 1883 2064 5516 11833
% Positive 3% 2% 4% 3% 3% 2% 2% 2% 3%
All
syndromes
MSD Number positive 23 292 187 502 208 250 573 1031 1533
Not hospitalised Number tested 741 1398 902 3041 1038 1644 3109 5791 8832
% Positive 3% 21% 21% 17% 20% 15% 18% 18% 17%
MSD Number positive 111 233 2 346 152 40 5 197 543
Hospitalised Number tested 337 437 8 782 440 175 41 656 1438
% Positive 33% 53% 25% 44% 35% 23% 12% 30% 38%
Acute
watery
MSD Number positive 0 284 125 409 198 207 515 920 1329
Not hospitalised Number tested 2 1315 485 1802 899 1258 2657 4814 6616
% Positive 0% 22% 26% 23% 22% 16% 19% 19% 20%
MSD Number positive 93 230 0 323 141 33 5 179 502
Hospitalised Number tested 171 411 3 585 397 129 35 561 1146
% Positive 54% 56% 0% 55% 36% 26% 14% 32% 44%
Deaths Number positive 4 0 0 4 1 2 5 8 12
(within 7 days of
enrolment)
Number VA adjudicated 4 0 0 4 0 1 2 3 7
Number VA confirmed as
diarrhoea
4 0 0 4 0 0 2 2 6
% VA confirmed as
diarrhoea
100% - - 100% - 0% 100% 67% 86%
Number positive (adjusted
for VA)
4 - - 4 - 0 5 5 10
Total deaths 5 0 1 6 12 12 7 31 37
% Positive * * * * * * * * 28%
*proportion positive not reported at country-level due to small numbers.
VA = verbal autopsy.
https://doi.org/10.1371/journal.pone.0183392.t003
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Proportion of rotavirus-positive U5 diarrhoea hospitalisations attributable
to rotavirus in GEMS
The AFe value (equivalent to the rotavirus attributable fraction among rotavirus-positive U5
diarrhoea hospitalisations) was 0.97 (95% CI 0.95–0.98) for all included GEMS sites (Table 4)
and all diarrhoea syndromes combined.
Using qPCR instead of EIA for rotavirus detection increased the AF by a factor of 1.08
(95% CI 1.02–1.14).
Proposed improvements
We propose a number of improvements for consideration by all groups involved in the devel-
opment of future rotavirus mortality estimates.
Reporting a standard set of minimum variables to describe all input data
points
Previous comparison exercises have stressed the need for input data points to be made avail-
able at the time estimates are published [4, 20]. Recent Guidelines for Accurate and Transpar-
ent Health Estimates Reporting (GATHER) have recommended publication of a spreadsheet
table with details about the data points used to inform estimates [22]. These guidelines do not
provide explicit guidance on the variables that should be reported. We suggest that the follow-
ing standard set of minimum variables should be reported: (a) author/reference; (b) country;
(c) sub-national location; (d) data collection period; (e) age range; (f) type of study; (g) type of
diagnostic test; (h) number of enteric pathogens tested; (i) inpatient/outpatient; (j) pre/post
Table 4. Rotavirus positive proportion, attributable fraction (AF) and attributable fraction in the exposed (AFe) for MSD cases <5yrs that were hos-
pitalised with all syndromes of diarrhoea in GEMS*.
Rotavirus positive proportion (includes extrapolation to
MSD cases that were not enrolled)
Value
Rotavirus positive proportion
(enrolled MSD cases only)**
Value
AF AFe
Value 95% CI Value 95% CI
Bangladesh 0.33 0.35 0.34 (0.30,
0.38)
0.96 (0.94,
0.98)
India 0.53 0.48 0.47 (0.42,
0.52)
0.99 (0.97,
1.00)
Pakistan 0.25 0.22 *** *** *** ***
ASIA 0.44 0.40 0.39 (0.36,
0.42)
0.97 (0.95,
0.98)
Gambia 0.35 0.29 0.28 (0.23,
0.33)
0.98 (0.96,
1.00)
Kenya 0.23 0.21 0.19 (0.13,
0.26)
0.91 (0.82,
0.99)
Mali 0.12 0.18 *** *** *** ***
AFRICA 0.30 0.26 0.24 (0.20,
0.29)
0.95 (0.91,
0.99)
ALL SITES 0.38 0.35 0.34 (0.31,
0.36)
0.97 (0.95,
0.98)
* Includes all syndromes of diarrhoea i.e. acute watery diarrhoea, acute bloody diarrhoea, and acute watery cases that became persistent after enrolment.
** These values were based on the children that were enrolled i.e. tested for rotavirus. Age-specific presentations of these values (0-11m, 12-23m, 24-59m)
were used in the calculation of AF and AFe.
*** Rotavirus-positive hospitalisation was rare in Mali (n = 5) and Pakistan (n = 2) so country-specific AF and AFe are not reported. The data for these
countries are included in the estimates for ASIA, AFRICA and ALL SITES.
https://doi.org/10.1371/journal.pone.0183392.t004
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implementation of rotavirus vaccine in the public sector, or preferably a more precise estimate
of rotavirus vaccine coverage with details about the source of sub-national or national coverage
data used; (k) type of clinical syndrome e.g. acute watery, all syndromes; (l) included/excluded
in final estimates; (m) justification if excluded; (n) rotavirus-positive proportion (unadjusted);
(o) rotavirus-positive proportion (adjusted); and, (p) description of adjustment applied. Inclu-
sion and exclusion criteria should be clearly documented, and any exclusions applied after
data extraction should be justified using a clearly defined framework for evaluating data qual-
ity and outliers.
Annual online publication of WHO surveillance data points in
spreadsheet format
A spreadsheet table should be published annually on the WHO web site to allow for potential
inclusion of GRSN data by all groups in future estimates. At a minimum, rotavirus-positive
proportions <5 years should be made available by country (aggregated across sub-national
sites) and by calendar year. The standard set of recommended variables described above
should be reported for each data point. To ensure the integrity and confidentiality of country
surveillance data and to protect the ownership of those who collect the data, this and similar
surveillance data should be aggregated and proper attribution should be given to countries
that share this data. Data for sub-national sites should be provided where possible and where
appropriate to do so. Given its importance to global estimates, efforts should also be made to
routinely publish the sub-national Indian NRSN data points in an accessible spreadsheet for-
mat, with data points presented by sub-national location and data year. Other partners and
networks that generate rotavirus-positive proportions are also encouraged to share their data
in an accessible format, wherever possible.
Extrapolation of data points to country-level estimates using methods
that appropriately capture between-country variation
Statistical regression modelling or finer levels of stratification than geographical region should
be used when and where possible to extrapolate sub-national data points to different countries.
The source of all sub-national, national and supranational indicators used to inform statistical
regression models (e.g. GDP per capita) should be clearly defined. Care should be taken to
ensure the coverage and impact of rotavirus vaccination is consistently captured at all levels of
the analysis, including U5 deaths, the proportion of U5 deaths due to diarrhoea, and the pro-
portion of U5 diarrhoea deaths due to rotavirus. Where possible, groups should extract and
test the importance of other potentially influential sub-national characteristics e.g. private/
public hospital, secondary/tertiary hospital, under-five mortality rate, proportion of patients
from rural areas etc. If it is not feasible to collect this information from all sites, then a more
detailed review of the GRSN dataset could be informative, and would allow comparison of sev-
eral sub-national sites within the same countries. Input data points should be disaggregated
into individual years of data collection to capture changes in the rotavirus-positive proportion
over time at country level; covariates linked to period effects (e.g. GDP per capita, under-five
mortality rate) should be carefully selected on the basis of their ability to reproduce observed
trends in the rotavirus-positive proportion.
Separation of the clinical syndromes of U5 diarrhoea hospitalisations
Rotavirus is not associated clinically with acute bloody or persistent diarrhoea, two diarrhoeal
syndromes that may also be proximal or distal causes of death. Rotavirus-positive proportions
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derived exclusively from acute watery U5 diarrhoea hospitalisations should be adjusted to
account for the proportion of total U5 diarrhoea hospitalisations that are acute watery. If the
rotavirus-positive proportion (r) is not reported for all clinical syndromes combined, then the
equation r = ab + c(1 − b) can be used, where a is the rotavirus-positive proportion among
acute watery U5 diarrhoea hospitalisations, b is the proportion of total U5 diarrhoea hospitali-
sations that are acute watery, and c is the rotavirus-positive proportion among acute bloody
and persistent U5 diarrhoea hospitalisations combined. In the absence of local data to inform
parameter b, our analysis shows that acute watery diarrhoea is likely to be responsible for no
more than 87% (95% CI 83–90%) of U5 diarrhoea hospitalisations. The true value of b is likely
to be lower because all data points included in the meta-analysis under-estimated the role of
persistent diarrhoea. Given that rotavirus is not associated clinically with acute bloody or per-
sistent diarrhoea, the value of parameter c is likely to be at least ~3% based on the rotavirus-
positivity observed in healthy controls in GEMS.
Accounting for uncertainty in the steps used to convert rotavirus-positive
proportions into rotavirus-attributable fractions
The frequent asymptomatic carriage of many pathogens in the stools of healthy controls neces-
sitates the calculation of attributable fractions. To estimate the proportion of rotavirus-positive
cases that are attributable only to rotavirus, the population attributable fraction estimated by
the equation r × AFe can be used, where r is the rotavirus-positive proportion reported among
U5 diarrhoea hospitalisations (all syndromes combined), and AFe is the rotavirus-attributable
fraction among rotavirus-positive U5 diarrhoea hospitalisations (all syndromes combined).
Because it is rare for diarrhoea surveillance studies to include diarrhoea-free controls, very few
studies allow calculation of AFe. GEMS does include diarrhoea-free controls so permits this
calculation; our new analysis of GEMS calculated the AFe to be 0.97 (95% CI 0.95–0.98). This
value was relatively consistent across all GEMS sites where it could be reported (Bangladesh,
India, Gambia, Kenya). This suggests that rotavirus is the attributable cause in almost all U5
rotavirus-positive diarrhoea hospitalisations. In a separate, related analysis, the rotavirus
attributable fraction was shown to increase by a factor of 1.08 (95% 1.02–1.14) when the more
sensitive qPCR test was used. This is similar (albeit slightly larger) than the adjustment made
to r to account for AFe, so both adjustments could reasonably be excluded, and this would
have a limited impact on central estimates of U5 rotavirus deaths. However, adjustments
applied to some pathogens and not others, would lead to inconsistent reporting of central esti-
mates (and uncertainty intervals) across enteric pathogens. These adjustments, and their
uncertainty, should therefore be reflected in future estimates for all enteric pathogens, includ-
ing rotavirus.
Further research into the clinical syndromes of U5 diarrhoea deaths, and
the real-world impact of rotavirus vaccines on those deaths
To date, all groups have assumed that the proportion of U5 diarrhoea hospitalisations caused
by rotavirus is a reasonable proxy for the proportion of U5 diarrhoea deaths caused by rotavi-
rus. This approach has been taken because hospitalisation is thought to be a good proxy for
diarrhoea that is sufficiently severe to lead to death. Two aspects of our analysis suggest this
assumption may lead to over-estimates of the number of U5 rotavirus deaths. First, we esti-
mate that acute watery diarrhoea is associated with 87% of diarrhoea hospitalisations but only
65% of U5 diarrhoea deaths. Higher case fatality ratios (CFR) have been reported for acute
bloody and persistent diarrhoea than acute watery diarrhoea [23] but more evidence on the
fatality of different syndromes is needed to corroborate this. In addition, the analysis of
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diarrhoeal deaths relied on verbal autopsy reports which may be prone to recall bias, and our
analysis of diarrhoea hospitalisations only included those that became persistent after admis-
sion. Second, rotavirus was detected in a higher proportion of U5 acute watery diarrhoea hos-
pitalisations than U5 acute watery diarrhoea deaths in GEMS (44% vs 28%). Thus, among
children that had access to treatment, rotavirus was estimated to be less fatal than other causes
of acute watery diarrhoea. However, more evidence is needed on the effect of treatment on the
proportion of acute watery diarrhoea deaths due to rotavirus; in communities without access
to treatment services, rotavirus may represent a larger proportion of acute watery diarrhoea
deaths. Another explanation for the lower rotavirus-positivity among U5 acute watery diar-
rhoea deaths, is that the number of deaths captured in the 7 days after enrolment (n = 37) were
too few to make a reliable assessment. Longer follow-up periods allow more deaths to be
included but it then becomes increasingly difficult to ascertain whether children who were
rotavirus-positive at the time of enrolment were still rotavirus-positive at the time of death,
and whether cases that were negative at enrolment had a new rotavirus episode prior to death.
Further evidence is needed from other geographical locations on the distribution of clinical
syndromes among U5 diarrhoea hospitalisations and deaths. This should include a more accu-
rate assessment of the role of persistent diarrhoea among U5 diarrhoea hospitalisations. More
importantly, efforts should be made to accurately capture the real-world impact of rotavirus
vaccines on U5 diarrhoea deaths in early introducing countries. This will provide critical
insights into the true contribution of rotavirus to U5 diarrhoea deaths in different locations.
Presenting and incorporating the uncertainty in parameters used to
derive U5 rotavirus deaths
The uncertainty interval around the central estimates of U5 rotavirus deaths should be explic-
itly defined (e.g. the type of confidence or prediction interval) and should incorporate uncer-
tainty in each of the three core parameters (number of U5 deaths, % due to diarrhoea, % due
Fig 5. Global estimates of the number of rotavirus deaths <5 years in the year 2013 by source of
estimates.
https://doi.org/10.1371/journal.pone.0183392.g005
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to rotavirus) as well as any other parameters used to adjust the original input data points e.g.
the parameters used to convert rotavirus-positive proportions into rotavirus-attributable
fractions.
Conclusion
There is considerable disagreement between global estimates of U5 rotavirus deaths, but it is
encouraging to note that estimates are converging over time, at least in absolute terms (Fig 5).
The aim of this analysis was not to recommend a single set of best estimates, but rather to
explain the reasons for differences, provide evidence to inform key areas of uncertainty, and
propose improvements for future estimates. Updates to GBD [24] and CHERG (now MCEE)
estimates were already well advanced during the course of this comparison study, and further
convergence is expected. The suggested improvements presented in this manuscript should be
incorporated, as far as possible, into future rotavirus mortality estimates. This is likely to be an
iterative and evolving process as new evidence emerges over time.
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